March 28, 2024
9:30AM-11:00AM (MT)
Presented by Dr. Kelly Johnson
Please note: CME not available for viewing the webinar recording.
Learning Objectives:
Registration closes on April 19, 2024
South County session: Santa Barbara, CA (in-person only)
Monday, April 22, 2024
11:00AM-1:00PM (PDT)
1.75 CME units at no cost
North County Session: Santa Maria, CA (in-person only)
Tuesday, April 23, 2024
11:00AM-1:00PM (PDT)
1.75 CME units at no cost
Presenter
Dr. Eric Tang, Chief, Medical & Scientific Affairs Section | Mpox Lead
STD Control Branch, California Department of Public Health
Learning Objectives
Thursday, March 14, 2024
Hybrid event. Please note: CME not available for viewing the recording.
Presented by:
Dr. Oliver Bacon
Medical Director, San Francisco City Clinic
San Francisco Department of Public Health
Dr. Franco Chevalier
Deputy Medical Director, San Francisco City Clinic
San Francisco Department of Public Health
Dr. Stephanie Cohen
Director, HIV/STI Prevention, Disease Control Branch,
San Francisco Department of Public Health
Dr. Kelly Johnson
Medical Director, California Prevention Training Center
Public Health Medical Officer, STD Control Branch, California Department of Public Health
Emcee: Dr. Ina Park
Principal Investigator, California Prevention Training Center
Description
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.
Learning Objectives
January 11, 2024
8:30AM-12:00PM (MST)
Presented by CAPTC Clinical Faculty
Recording available 2 weeks after the webinar. Please note: CME not available for viewing the webinar recording.
Presenters:
Learning Objectives:
Describe the varied clinical manifestations of syphilis in adults & congenital syphilis (CS) in infants
Recognize that there are two different screening algorithms used to diagnose syphilis in adults
Define adequate treatment for syphilis, including during pregnancy
List at least 3 strategies to prevent syphilis in adults and infants
Presented by Drs. Kathleen Jacobson and Wyatt Hanft
December 5, 2023
Learning Objectives:
Please note: CME not offered for viewing the recording of the update
California Clinicians:
Do you have an URGENT congenital syphilis case and need SAME DAY expert consultation?
January 1 – March 31, 2024
www.stdccn.org
October 17, 2023
9AM-5PM (HST)
Honolulu, HI / Virtual
1-day in-person and virtual training covering the following topics:
Presented by:
Learning Objectives
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.
This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.
For more information on EPT and why it should be prescribed, see “Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers – What is EPT and Why Should I Prescribe It?”
Thursday, November 2, 2023
2:00-5:00PM (PDT)
The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
Learning Objectives